FEATURE ARTICLE
Synthesis of Functionalized Pyrrolidines
1581
HRMS (ESI): m/z [M + Na]+ calcd for C21H39NNaO3SSi2:
HRMS (ESI): m/z [M + Na]+ calcd for C34H41NNaO3SSi2:
464.2081; found: 464.2078.
622.2238; found: 622.2230.
(2S,3R,4R,5R)-2-Isopropyl-4-(dimethylphenylsilyl)-5-[(dimeth-
ylphenylsilyl)methyl]-1-tosylpyrrolidin-3-ol (1b); Typical Pro-
cedure
(2S,3R,4R,5R)-2-[(tert-Butyldimethylsiloxy)methyl]-4-(dimeth-
ylphenylsilyl)-5-[(dimethylphenylsilyl)methyl]-1-tosylpyrroli-
din-3-ol (1f)
To a stirred soln of aldehyde 2a (45 mg, 176 mmol) in CH2Cl2 (3.5
mL) cooled to –78 °C was added 1 M MeAlCl2 in hexanes (360 mL)
with a syringe followed by addition of 3e (115 mL, 0.35 mmol). The
resulting mixture was stirred at –78 °C for 2 h. The reaction was
quenched by addition of sat. aq soln NH4Cl (5 mL) and extracted
with CH2Cl2 (3 × 5 mL). The combined organic phases were dried
(MgSO4), filtered and evaporated to give a colorless oil. Flash chro-
matography (silica gel, pentane–EtOAc, 5:1) of the residue yielded
1b as a white solid (66 mg, 67%).
[a]D25 –3.4 (c 0.55, CH2Cl2).
IR (neat): 3490, 2950, 1350, 1160 cm–1.
1H NMR (500 MHz, CDCl3): d = 7.56 (d, J = 8.2 Hz, 2 H), 7.45–
7.23 (m, 12 H), 3.99 (dd, J = 10.1, 4.7 Hz, 1 H), 3.88–3.86 (m, 2 H),
3.80 (ddd, J = 8.8, 5.9, 3.1 Hz, 1 H), 3.54–3.51 (m, 1 H), 3.45 (d,
J = 3.3 Hz, 1 H), 2.42 (s, 3 H), 1.69 (dd, J = 15.7, 8.8 Hz, 1 H), 1.47
(t, J = 5.7 Hz, 1 H), 1.18 (dd, J = 15.7, 3.1 Hz, 1 H), 0.89 (s, 9 H),
0.27 (s, 3 H), 0.26 (s, 3 H), 0.10 (s, 6 H), 0.06 (s, 3 H), 0.05 (s, 3 H).
13C NMR (125 MHz, CDCl3): d = 143.4, 139.2, 136.6, 135.4, 134.0,
133.9, 129.6, 129.3, 128.8, 127.9, 127.7, 127.6, 75.1, 64.1, 62.8,
60.3, 39.6, 26.7, 25.8, 21.5, 18.0, –1.5, –1.8, –4.0, –4.2, –5.4, –5.5.
MS (ESI): m/z (%) = 690 (100) [M + Na]+.
HRMS (FAB): m/z [M + Na]+ calcd for C35H53NNaO4SSi3:
[a]D25 –55.8 (c 1.0, CH2Cl2).
IR (neat): 3510, 2920, 1330, 1160 cm–1.
1H NMR (500 MHz, CDCl3): d = 7.56 (d, J = 8.1 Hz, 2 H), 7.42–
7.26 (m, 12 H), 3.80 (dt, J = 8.8, 3.5 Hz, 1 H), 3.53–3.48 (m, 1 H),
3.30 (dd, J = 8.7, 6.6 Hz, 1 H), 2.47–2.43 (m, 4 H), 2.05–1.90 (m, 1
H), 1.33 (dd, J = 9.6, 8.0 Hz, 1 H), 1.23 (dd, J = 15.1, 9.1 Hz, 1 H),
1.09 (d, J = 6.6 Hz, 3 H), 1.07 (d, J = 6.6 Hz, 3 H), 1.00 (dd,
J = 15.1, 3.5 Hz, 1 H), 0.45 (s, 3 H), 0.39 (s, 3 H), 0.10 (s, 6 H).
13C NMR (125 MHz, CDCl3): d = 143.2, 140.3, 136.7, 136.1, 133.9,
133.7, 129.7, 129.6, 128.6, 128.2, 127.7, 127.6, 74.5, 68.1, 58.2,
42.5, 29.5, 27.9, 21.5, 21.2, 20.8, –1.9, –3.0, –4.1, –4.3.
690.2895; found: 690.2899.
(2S*,3R*,4R*,5R*)-2-Allyl-4-(dimethylphenylsilyl)-5-[(dimeth-
ylphenylsilyl)methyl]-1-tosylpyrrolidin-3-ol (1g)
IR (neat): 3510, 2950, 1340, 1160 cm–1.
1H NMR (500 MHz, CDCl3): d = 7.63–7.60 (m, 2 H), 7.46–7.26 (m,
12 H), 5.86–5.83 (m, 1 H), 5.08 (d, J = 17.2 Hz, 1 H), 5.06 (d,
J = 10.2 Hz, 1 H), 3.93 (dt, J = 8.1, 5.3 Hz, 1 H), 3.73 (q, J = 5.4 Hz,
1 H), 3.55 (dt, J = 8.1, 6.0 Hz, 1 H), 2.65–2.61 (m, 1 H), 2.46–2.42
(m, 4 H), 1.52 (dd, J = 14.8, 7.8 Hz, 1 H), 1.46 (d, J = 4.6 Hz, 1 H),
1.39 (t, J = 5.7 Hz, 1 H), 1.29–1.25 (m, 2 H), 0.32 (s, 3 H), 0.30 (s,
3 H), 0.10 (s, 3 H), 0.05 (s, 3 H).
MS (ESI): m/z (%) = 588 (100) [M + Na]+.
HRMS (ESI): m/z [M + H]+ calcd for C31H44NO3SSi2: 566.2575;
found: 566.2561.
(2S,3R,4R,5R)-4-(Dimethylphenylsilyl)-5-[(dimethylphenyl-
silyl)methyl]-2-methyl-1-tosylpyrrolidin-3-ol (1d)
[a]D25 –35.8 (c 0.65, CH2Cl2).
IR (neat): 3500, 2930, 1340, 1160 cm–1.
13C NMR (125 MHz, CDCl3): d = 143.3, 139.4, 136.5, 136.2, 135.4,
133.9, 133.8, 129.6, 129.5, 128.8, 128.0, 127.72, 127.68, 117.1,
74.3, 63.7, 59.4, 40.3, 35.2, 28.2, 21.5, –1.8, –2.4, –3.8, –4.5.
1H NMR (500 MHz, CDCl3): d = 7.61 (d, J = 8.4 Hz, 2 H), 7.51–
7.48 (m, 2 H), 7.40–7.24 (m, 10 H), 3.82 (dt, J = 7.4, 4.1 Hz, 1 H),
3.58 (p, J = 6.7 Hz, 1 H), 3.48 (dd, J = 12.2, 6.7 Hz, 1 H), 2.43 (s, 3
H), 1.62 (dd, J = 14.8, 7.4 Hz, 1 H), 1.37 (t, J = 7.5 Hz, 1 H), 1.27
(dd, J = 14.8, 4.2 Hz, 1 H), 1.23 (d, J = 6.6 Hz, 1 H), 1.12 (d, J = 5.4
Hz, 1 H), 0.88 (d, J = 6.5 Hz, 1 H), 0.40 (s, 3 H), 0.33 (s, 3 H), 0.12
(s, 3 H), 0.08 (s, 3 H).
13C NMR (125 MHz, CDCl3): d = 143.2, 139.7, 136.4, 135.5, 133.9,
133.8, 129.6, 129.5, 128.8, 128.1, 127.7, 127.6, 74.1, 59.5, 59.2,
39.4, 27.1, 21.5, 16.6, –1.5, –1.8, –3.7, –4.5.
MS (ESI): m/z (%) = 586 (100) [M + Na]+.
HRMS (ESI): m/z [M + H]+ calcd for C31H42NO3SSi2: 564.2418;
found: 564.2409.
(2S,3R,4R,5R)-2-[3-(tert-Butyldiphenylsiloxy)propyl]-4-(di-
methylphenylsilyl)-5-[(dimethylphenylsilyl)methyl]-1-tosyl-
pyrrolidin-3-ol (1h)
[a]D25 –19.0 (c 1.0, CH2Cl2).
IR (neat): 2950, 1160, 1110 cm–1.
1H NMR (500 MHz, CDCl3): d = 7.61–7.58 (m, 4 H), 7.49–7.45 (m,
2 H), 7.34–7.12 (m, 18 H), 3.75 (q, J = 6.8 Hz, 1 H), 3.64–3.58 (m,
2 H), 3.44–3.40 (m, 2 H), 2.34 (s, 3 H), 1.68–1.49 (m, 3 H), 1.41 (d,
J = 5.4 Hz, 1 H), 1.28–1.22 (m, 2 H), 1.10 (dd, J = 14.9, 5.5 Hz, 1
H), 0.97 (s, 9 H), 0.29 (s, 3 H), 0.25 (s, 3 H), 0.04 (s, 3 H), 0.03 (s,
3 H).
13C NMR (125 MHz, CDCl3): d = 143.1, 139.8, 136.6, 135.9, 135.6,
135.5, 133.9, 133.82, 133.80, 133.77, 129.6, 129.4, 128.7, 128.1,
127.7, 127.6, 73.5, 63.8, 63.7, 58.9, 40.7, 31.9, 28.9, 28.6, 26.9,
25.9, 22.7, 21.4, 19.2, 14.1, –1.8, –2.3, –4.1.
MS (ESI): m/z (%) = 560 (100) [M + Na]+.
HRMS (ESI): m/z [M + H]+ calcd for C29H40NO3SSi2: 538.2267;
found: 538.2240.
(2S,3R,4R,5R)-4-(Dimethylphenylsilyl)-5-[(dimethylphenyl-
silyl)methyl]-2-phenyl-1-tosylpyrrolidin-3-ol (1e)
[a]D25 +18.9 (c 0.93, CH2Cl2).
IR (neat): 3520, 3070, 2950, 1330, 1160 cm–1.
1H NMR (500 MHz, CDCl3): d = 7.47–7.08 (m, 19 H), 4.55 (d,
J = 4.7 Hz, 1 H), 4.35 (dt, J = 11.7, 0.8 Hz, 1 H), 3.98 (d, J = 4.4 Hz,
1 H), 2.33 (s, 3 H), 1.92 (dd, J = 14.2, 11.7 Hz, 1 H), 1.53–1.50 (m,
2 H), 1.08 (br s, 1 H), 0.23 (s, 3 H), 0.17 (s, 3 H), 0.08 (s, 3 H), 0.03
(s, 3 H).
MS (ESI): m/z (%) = 842 (100) [M + Na]+.
HRMS (FAB): m/z [M + Na]+ calcd for C47H61NNaO4SSi3:
842.3521; found: 842.3528.
13C NMR (125 MHz, CDCl3): d = 143.0, 138.6, 136.8, 136.5, 136.3,
134.0, 133.9, 129.4, 129.2, 129.0, 128.5, 128.1, 127.9, 127.8, 70.1,
60.4, 39.9, 28.2, 21.4, –1.9, –2.6, –3.3, –4.8.
(E)-1,3-Bis(trichlorosilyl)prop-1-ene (3c)
IR (neat): 1610, 1390, 1090 cm–1.
1H NMR (500 MHz, CDCl3): d = 6.60 (dt, J = 17.9, 7.6 Hz, 1 H),
5.99–5.95 (m, 1 H), 2.59 (dd, J = 7.9, 1.3 Hz, 2 H).
MS (ESI): m/z (%) = 622 (100) [M + Na]+.
Synthesis 2007, No. 10, 1576–1583 © Thieme Stuttgart · New York